TECX Share Price Performance
US$19.32
-26.75 (-58.06%)
Price US$19.32
Share PriceUS$19.32
We Think Tectonic Therapeutic (NASDAQ:TECX) Can Afford To Drive Business Growth
May 20
Tectonic Therapeutic, Inc. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 1 Fair Values set on narratives written by author
TECX Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Tectonic Therapeutic, Inc. Key Details
About TECX
- Founded
- n/a
- Employees
- 51
- CEO
- WebsiteView website
Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein-coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company’s lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts.
